One-carbon metabolites, B vitamins and associations with systemic inflammation and angiogenesis biomarkers among colorectal cancer patients

• Verfasst von: Kiblawi, Rama [VerfasserIn]
• Verfasst von: Gigić, Biljana [VerfasserIn]
• Verfasst von: Schrotz-King, Petra [VerfasserIn]
• Verfasst von: Habermann, Nina [VerfasserIn]
• Verfasst von: Schneider, Martin [VerfasserIn]
• Verfasst von: Ulrich, Alexis [VerfasserIn]
• Titel: One-carbon metabolites, B vitamins and associations with systemic inflammation and angiogenesis biomarkers among colorectal cancer patients
• Titelzusatz: results from the ColoCare Study
• Verf.angabe: Rama Kiblawi, Andreana N. Holowatyj, Biljana Gigic, Stefanie Brezina, Anne J.M.R. Geijsen, Jennifer Ose, Tengda Lin, Sheetal Hardikar, Caroline Himbert, Christy A. Warby, Jürgen Böhm, Martijn J.L. Bours, Fränzel J.B. van Duijnhoven, Tanja Gumpenberger, Dieuwertje E. Kok, Janna L. Koole, Eline H. van Roekel, Petra Schrotz-King, Arve Ulvik, Andrea Gsur, Nina Habermann, Matty P. Weijenberg, Per Magne Ueland, Martin Schneider, Alexis Ulrich, Cornelia M. Ulrich and Mary Playdon
• E-Jahr: 2020
• Jahr: 5 February 2020
• Umfang: 14 S.
• Fussnoten: Gesehen am 03.07.2020
• Titel Quelle: Enthalten in: British journal of nutrition
• Ort Quelle: Cambridge : Cambridge University Press, 1947
• Jahr Quelle: 2020
• Band/Heft Quelle: 123(2020), 10, Seite 1187-1200
• ISSN Quelle: 1475-2662
• DOI: doi:10.1017/S0007114520000422
• Datenträger: Online-Ressource
• Sprache: eng
• Sach-SW: Angiogenesis
• Sach-SW: 3-hydroxykynurenine:xanthurenic acid ratio
• Sach-SW: 5-methyl-tetrahydrofolate
• Sach-SW: acetyl-para-aminobenzoylglutamic acid
• Sach-SW: B vitamins
• Sach-SW: C-reactive protein
• Sach-SW: colorectal cancer
• Sach-SW: Colorectal cancer
• Sach-SW: Folate
• Sach-SW: folic acid
• Sach-SW: Gaussian graphical model
• Sach-SW: Inflammation
• Sach-SW: One-carbon metabolism
• Sach-SW: para-aminobenzoylglutamic acid
• Sach-SW: pyridoxal
• Sach-SW: pyridoxal-5’-phosphate
• Sach-SW: pyridoxic acid
• Sach-SW: serum amyloid A
• Sach-SW: vascular endothelial growth factor
• Sach-SW: Vitamin B6
• K10plus-PPN: 1696969557

Abstract

B vitamins involved in one-carbon metabolism have been implicated in the development of inflammation- and angiogenesis-related chronic diseases, such as colorectal cancer (CRC). Yet, the role of one-carbon metabolism in inflammation and angiogenesis among CRC patients remains unclear. The objective of this study was to investigate associations of components of one-carbon metabolism with inflammation and angiogenesis biomarkers among newly diagnosed CRC patients (n 238) in the prospective ColoCare Study, Heidelberg. We cross-sectionally analysed associations between twelve B vitamins and one-carbon metabolites and ten inflammation and angiogenesis biomarkers from pre-surgery serum samples using multivariable linear regression models. We further explored associations among novel biomarkers in these pathways with Spearman partial correlation analyses. We hypothesised that pyridoxal-5’-phosphate (PLP) is inversely associated with inflammatory biomarkers. We observed that PLP was inversely associated with C-reactive protein (CRP) (r -0·33, Plinear < 0·0001), serum amyloid A (SAA) (r -0·23, Plinear = 0·003), IL-6 (r -0·39, Plinear < 0·0001), IL-8 (r -0·20, Plinear = 0·02) and TNFα (r -0·12, Plinear = 0·045). Similar findings were observed for 5-methyl-tetrahydrofolate and CRP (r -0·14), SAA (r -0·14) and TNFα (r -0·15) among CRC patients. Folate catabolite acetyl-para-aminobenzoylglutamic acid (pABG) was positively correlated with IL-6 (r 0·27, Plinear < 0·0001), and pABG was positively correlated with IL-8 (r 0·21, Plinear < 0·0001), indicating higher folate utilisation during inflammation. Our data support the hypothesis of inverse associations between PLP and inflammatory biomarkers among CRC patients. A better understanding of the role and inter-relation of PLP and other one-carbon metabolites with inflammatory processes among colorectal carcinogenesis and prognosis could identify targets for future dietary guidance for CRC patients.